Supercharge Your Innovation With Domain-Expert AI Agents!

Pharmaceutical composition for treating rheumatoid arthritis

A rheumatoid and composition technology, applied in the direction of drug combination, antipyretics, anti-inflammatory agents, etc., can solve the lack of specific and effective treatment methods for rheumatoid arthritis, and there is no report on the treatment or alleviation of rheumatoid arthritis , toxic adverse effects and other issues

Inactive Publication Date: 2020-10-16
和田地区维吾尔医医院
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Rheumatoid arthritis still lacks specific and effective treatment methods. Current treatment methods include drug therapy, physical therapy, and surgical treatment. Among them, drug therapy is the first choice for the treatment of rheumatoid arthritis, but long-term medication toxicity and adverse effects are relatively large
[0003] Nutmeg and calamus, the literature has not reported that each has the effect of treating or alleviating rheumatoid arthritis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating rheumatoid arthritis
  • Pharmaceutical composition for treating rheumatoid arthritis
  • Pharmaceutical composition for treating rheumatoid arthritis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] The medicinal composition for treating rheumatoid arthritis comprises the following active ingredients: 400 grams of nutmeg and 400 grams of calamus calamus.

Embodiment 2

[0017] The medicinal composition for treating rheumatoid arthritis comprises the following active ingredients: 400 grams of nutmeg, 400 grams of calamus calamus and 400 grams of colchicum.

Embodiment 3

[0019] The medicinal composition for treating rheumatoid arthritis comprises the following active ingredients: 400 grams of nutmeg, 400 grams of calamus calamus and 200 grams of aloe extract.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating rheumatoid arthritis. The pharmaceutical composition comprises the following active ingredients in parts by weight: 2 parts of semen myristicae, 2 parts of rhizoma acori graminei, and an aloe extract, rhizoma curcumae and / or colchicine. Experiments prove that the raw material semen myristicae and rhizoma acori graminei without treatment of rheumatoid arthritis are adopted as raw material to form the composition, the composition has the effect of treating or relieving rheumatoid arthritis, and colchicines, rhizoma curcumae and / oraloe extracts are compounded, so that the effect of treating or relieving rheumatoid arthritis can be improved, and meanwhile, the irritation of the medicine to the skin is relieved.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine. More specifically, it relates to pharmaceutical compositions for the treatment of rheumatoid arthritis. Background technique [0002] Rheumatoid arthritis is a systemic autoimmune disease that chronically and symmetrically invades joints and periarticular tissues, with joint synovial lesions as the main lesion. The pathogenesis of rheumatoid arthritis has not yet been fully clarified, and the etiology of the pathogenesis is complex. During the pathogenesis, some cell subsets are aggregated and activated, such as the release of T cells and T cell-derived cytokines, B cells and subsequent autoantibody responses, and macrophages. , fibroblast-like cells, and the production of a large number of pro-inflammatory cytokines. Rheumatoid arthritis still lacks specific and effective treatment methods. Current treatment methods include drug therapy, physical therapy, and surgical treatment. Amo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/888A61K36/896A61K36/9066A61P19/02A61P29/00
CPCA61K36/185A61K36/886A61K36/888A61K36/896A61K36/9066A61P19/02A61P29/00A61K2300/00
Inventor 乃比江·阿布都热西提阿力木江·阿布地热力木吾布力卡生木·艾合买提阿迪力·艾斯托拉热汗古丽·买买提江阿卜力克木·奥布力迪力穆拉提·买买吐送
Owner 和田地区维吾尔医医院
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More